JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: Implications for early diagnosis

A 52 year-old man with Erdheim-Chester Disease (ECD) (a non-Langerhans polyostotic sclerosing histiocytosis) had next-generation sequencing (NGS) performed as part of his diagnostic workup. In addition to the tissue BRAF V600E mutation that is found in over 50% of ECD cases, he was also found to hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Michael Y., Kato, Shumei, Wang, Huan-You, Lin, Jonathan H., Lanman, Richard B., Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Bedside to Bench Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067874/
https://www.ncbi.nlm.nih.gov/pubmed/29565699
http://dx.doi.org/10.1080/15384047.2018.1450120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067874/
https://www.ncbi.nlm.nih.gov/pubmed/29565699
http://dx.doi.org/10.1080/15384047.2018.1450120

Ejemplares similares